Streetbeat News

Stock Prices

BZ

Kanzhun reported Q3 adjusted earnings of $0.22 per share, an 83.33% increase from $0.12 per share in the same period last year. Sales rose 32.91% to $220.21M from $165.68M YoY.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 11:09 am

RMTI

Rockwell Medical (NASDAQ:RMTI) reported Q3 earnings with an EPS of $-0.07, beating estimates by 30% against an expected $-0.1. Revenue increased by $5.08 million compared to the same period last year. Despite beating this quarter, the company's share price dropped 3.16% the day after last quarter's earnings miss.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 11:05 am

HD

Home Depot (NYSE:HD) reported Q3 earnings with an EPS of $3.81, beating estimates by 6.42% but with a revenue decrease of $1.16 billion from the same period last year. The company had previously beaten EPS estimates last quarter, which resulted in a slight share price increase the following day.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 11:05 am

XPEV

XPENG, a Chinese electric vehicle manufacturer, is set to unveil its flagship Multi-Purpose Vehicle (MPV), the XPENG X9, at Auto Guangzhou 2023. This event is significant as it showcases the company's latest advancements in the electric vehicle space and could potentially influence investor sentiment and the company's stock performance.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 11:05 am

CSIQ

Canadian Solar reported a decrease in earnings per share (EPS) to $0.32 in Q3 from $1.12 year-over-year, and sales of $1.85 billion, which fell short of the $2.03 billion estimate.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 11:03 am

HD

Home Depot reported a decline in Q3 comparable sales by 3.1% overall, with a more pronounced decrease in the US at 3.5%.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 11:02 am

HD

Home Depot (NYSE:HD) exceeded Q3 earnings and sales estimates with an EPS of $3.81, surpassing the $3.58 forecast, and sales of $37.71B, beating the $35.66B estimate. However, this reflects a 10.14% decrease in EPS and a 2.99% drop in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 11:01 am

CARA

Piper Sandler analyst David Amsellem has downgraded Cara Therapeutics (NASDAQ:CARA) from Overweight to Neutral and significantly reduced the price target from $12 to $1, indicating a bearish outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 10:59 am

AMD

INTC

NVDA

SOXX

Roth MKM analyst Suji DeSilva initiated coverage of AMD with a Buy rating and a $125 price target, citing the company's differentiated portfolio and strong position in the AI infrastructure market. AMD's data center revenue is expected to grow significantly, with AI Instinct product sales projected to reach $400 million in Q4 and $2 billion in 2024. AMD's market share in x86-based server processors has risen to 25%, outperforming Intel's data center revenue growth. The company is also positioned to compete with Nvidia in AI, leveraging open-source tools as an alternative to Nvidia's CUDA. AMD's stock has risen 80.31% this year, outpacing the iShares Semiconductor ETF's 41.85% gain.

Portfolio Pulse from Shanthi Rexaline

November 14, 2023 | 10:57 am

ARKO

BMO Capital analyst Kelly Bania has downgraded ARKO Corp (NASDAQ:ARKO) from Outperform to Market Perform and reduced the price target from $10 to $8.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 10:56 am